https://www.cytodyn.com/newsroom/press-releases/de
Post# of 148280
What is Cytodyn's current relationship with Progenics? The above link shows that we purchase Pro 140 (leronlimab) for of $3.5 million and subsequent milestone payments conditioned on successful continued clinical development of PRO 140 and a royalty payment to Progenics based on net sales upon commercialization following final FDA approval.
Has other payments been made to Progenics and what happens if we get approval from the FDA? Is this only with respect to HIV or is to all products? Do we the royalty rate?
Thanks in advance for your assistance.